ALNYAlnylam Pharmaceuticals Inc
+2.5% today · −51.2% over a year
No score: too little data.
Quality: among the best of its peers; Trend: among the weakest. No dividend.
Alnylam Pharmaceuticals Inc (ALNY) belongs to the Health care sector and is listed on Nasdaq; country: United States. Its market value is about €27.9B. Over the past 12 months the price changed by −51.2%, with an annualised volatility of 51% and a largest fall of 57%.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- 12-month trend (ex last month)weighs on the score · better than 6% of peers
- Gross profit growth / assets (5 y)supports the score · better than 85% of peers
- Return on equitysupports the score · better than 97% of peers
Red flags and notes
- Caution. Share count growing 3–10 % a year over three years. More in the glossary → Share count growing 3–10 % a year over three years.
- Caution. Accruals or the Beneish M-score are in the watch zone. More in the glossary → Accruals or the Beneish M-score are in the watch zone.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/E
- 42.4
- P/B
- 23.0
- Market cap (EUR)
- €27.9B
Profitability and debt
- Return on equity
- 76.8%
Dividends
- Dividend yield
- 0.00%
- Years of dividend growth
- 0
Returns and risk
- 1 day
- +2.5%
- 1 month
- −9.0%
- 1 year
- −51.2%
- Volatility, 1 yr
- 51.3%
- Max drawdown, 1 yr
- −57.3%
- Beta
- 0.96
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector and region, closest in market value.
| ZTSZoetis | 7/10 | 3.3% | −45.5% |
|---|---|---|---|
| DXCMDexCom Inc | 9/10 | 0.0% | 13.6% |
| LHLabcorp Holdings | 8/10 | 0.8% | 40.1% |
| CNCCentene Corporation | 7/10 | 0.0% | 102.0% |
| MTDMettler Toledo | 8/10 | 0.0% | 20.9% |
| WSTWest Pharmaceutical Services I | 9/10 | 0.2% | 42.8% |
| GEHCGE HealthCare Technologies | 6/10 | 0.2% | −4.3% |
| DGXQuest Diagnostics | 10/10 | 1.4% | 40.1% |
News and filings
No recent news or filings in our sources.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 1 entry
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| First rating | —/10 | — · — | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.